Search tips
Search criteria 


Logo of bmcnephBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Nephrology
BMC Nephrol. 2012; 13: 135.
Published online 2012 October 12. doi:  10.1186/1471-2369-13-135
PMCID: PMC3489555

The providing resources to enhance African American patients’ readiness to make decisions about kidney disease (PREPARED) study: protocol of a randomized controlled trial



Living related kidney transplantation (LRT) is underutilized, particularly among African Americans. The effectiveness of informational and financial interventions to enhance informed decision-making among African Americans with end stage renal disease (ESRD) and improve rates of LRT is unknown.


We report the protocol of the Providing Resources to Enhance African American Patients’ Readiness to Make Decisions about Kidney Disease (PREPARED) Study, a two-phase study utilizing qualitative and quantitative research methods to design and test the effectiveness of informational (focused on shared decision-making) and financial interventions to overcome barriers to pursuit of LRT among African American patients and their families. Study Phase I involved the evidence-based development of informational materials as well as a financial intervention to enhance African American patients’ and families’ proficiency in shared decision-making regarding LRT. In Study Phase 2, we are currently conducting a randomized controlled trial in which patients with new-onset ESRD receive 1) usual dialysis care by their nephrologists, 2) the informational intervention (educational video and handbook), or 3) the informational intervention in addition to the option of participating in a live kidney donor financial assistance program. The primary outcome of the randomized controlled trial will include patients’ self-reported rates of consideration of LRT (including family discussions of LRT, patient-physician discussions of LRT, and identification of a LRT donor).


Results from the PREPARED study will provide needed evidence on ways to enhance the decision to pursue LRT among African American patients with ESRD.

Trial registration NCT01439516

Keywords: Shared decision-making, Live kidney transplantation, Live kidney donation, Chronic kidney disease, End stage renal disease


African Americans are less likely than Whites to receive kidney transplants, despite their up to four-fold greater likelihood to develop end stage renal disease (ESRD) [1]. Several factors contribute to lower rates of kidney transplantation for African Americans, including immunological incompatibility of deceased donor kidneys [2,3], lower rates of referral of African Americans for transplantation [4-6], lower rates of deceased kidney donation [7], less access to health care [5,8], less desire for kidney transplantation [9,10], and suboptimal discussions about living related kidney transplantation (LRT) between recipients, their families, and health care providers [11]. LRT offers patients an opportunity to bypass many barriers to receipt of deceased kidney transplants, and it improves survival and quality of life at a lesser cost than dialysis care [12-16]. However, African Americans are less likely than Whites to receive LRTs, further exacerbating race disparities in transplant rates [17].

African Americans’ poor awareness of the risks and benefits of LRT as well as their limited access to potential live kidney donors represent important potential barriers to their receipt of LRT [18]. Evidence suggests African Americans are less likely than their White counterparts to be aware of LRT as a treatment option, even when they are under the care of a nephrologist [19,20]. Evidence also suggests African Americans have difficulty identifying potential live kidney donors that successfully complete the donation process [21]. Lack of financial assistance with indirect costs associated with LRT, such as expenses from travel/lodging, lost work, and home health assistance for donors may pose a significant barrier to live kidney donation, particularly among African Americans [22]. A recent study of the general public identified that potential living donors concerned about out of pocket expenses related to donation had 50% lesser odds of being willing to donate when compared to persons not concerned about expenses [23]. In a separate study, an overwhelming majority of the U.S. general public reported having favorable attitudes toward financial assistance programs which could help cover indirect costs for living donors, including costs associated with leave from work, with African Americans reporting significantly more favorable attitudes towards some forms of financial assistance when compared to Whites [24]. To date, however, it is unknown whether educational or financial assistance to address gaps in patients’ knowledge and financial barriers to receipt of LRT could be effective mechanisms of improving African Americans’ access to this life-saving therapy.

We describe the protocol of a two-phase study in which we 1) developed informational and financial interventions to enhance African Americans’ shared and informed decision-making about LRT and 2) are currently testing the effectiveness of these interventions in a randomized controlled trial.


Study design summary

The Providing Resources to Enhance African American Patients’ Readiness to Make Decisions about Kidney Disease (PREPARED) Study is a two-phase study to design and test the effectiveness of informational and financial interventions to overcome barriers to pursuit of LRT among African American patients and families. In Phase 1, we developed an informational intervention, including an educational video and handbook, to assist patients with new-onset ESRD and their families with informed decision-making regarding the choice of LRT and other renal replacement therapy options. We also developed a financial assistance intervention for potential live kidney donors identified by patients with ESRD, which we adapted from an existing national program [25]. In Phase 2, we are currently conducting a randomized controlled trial to assess the individual and combined effectiveness of informational and financial interventions on patients’ and their families’ consideration or pursuit of LRT as a treatment. The Johns Hopkins School of Medicine Institutional Review Board has approved all study procedures.

Phase I: Development of informational and financial assistance interventions

To inform the development of informational interventions, we performed qualitative focus groups as well as directed interviews of patients with kidney disease and their family members. Full details have been previously published [26]. We also performed systematic reviews of scientific evidence describing the risks and benefits of LRT compared to other forms of renal replacement therapy [27-30]. We reviewed the published literature describing ethical and legal forms of potential financial assistance for patients and living donors seeking LRT (e.g. reimbursement for childcare expenses, lodging/travel expenses, and time lost from work) to inform intervention development [31-40]. We also reviewed publicly available information on a national live donor financial assistance program to inform the development of our donor financial assistance intervention [25]. We performed several iterative revisions of informational materials, incorporating feedback from patients with kidney disease and their family members.

Description of informational intervention

The informational intervention consists of an educational video and written handbook that we designed to assist patients with kidney disease (potential transplant recipients) and their family members (potential donors) with making informed decisions about LRT. The informational materials are intended to expose potential recipients and donors to a variety of experiences of others receiving various forms for renal replacement therapy, including LRT.

The educational video features patients and their family members describing their experiences with LRT as well as with other forms of renal replacement therapy (peritoneal dialysis, home hemodialysis, in-center hemodialysis, and medical management with no dialysis or transplant). The educational video also features medical professionals (a transplant nephrologist, a transplant social worker, a general nephrologist and a dialysis social worker) describing positive and negative experiences patients could have with the various forms of renal replacement therapy. The written handbook provides a summary of scientific evidence describing the risks and benefits of LRT and other forms of renal replacement therapy in lay language. Together, the educational video and handbook promote shared and informed decision-making regarding LRT on the part of patients, their families, and health care providers by achieving commonly accepted goals for informational shared decision-making aids [41].

Description of the financial assistance intervention

We will offer potential recipients the opportunity to enroll their family members or friends (potential donors) in a program that will reimburse potential donors up to $1600.00 for approved financial assistance through the study by submitting formal original invoices, receipts, and other documentation of their qualifying medical and non-medical expenses related to live kidney donation evaluation, donation, or convalescence (up to 10 weeks post live donor/LRT procedures). Qualifying expenses include travel/lodging, meals, incidental expenses (e.g., parking), lost wages, and childcare costs incurred by the potential donor as part of: (1) donor evaluation, clinic visit or hospitalization, (2) hospitalization for the living donor surgical procedure, and/or (3) medical or surgical follow-up clinic visits or hospitalization within 90 days following the living donation procedure. Participants will be permitted to utilize the $1600.00 for multiple approved purposes, as long as the total reimbursement is not greater than $1600.00. Also, more than one potential donor may draw from these funds, as long as the total value of reimbursed expenses does not exceed $1600.00 per patient study participant. This program covers a broader array of expenses related to live kidney donation than other national programs and does not limit reimbursement of potential donors based on their personal incomes.

Phase 2: Randomized controlled trial assessing the individual and combined effectiveness of informational and financial interventions

We are currently conducting a randomized controlled trial to assess the individual and combined effectiveness of informational and financial assistance interventions to enhance rates of LRT. The combined intervention will be tested to detect any additive or multiplicative effects of the financial assistance intervention. Recruitment of study participants began in August, 2012. Figure Figure11 contains a flow diagram demonstrating the overall structure of our study.

Figure 1
Flow of PREPARED Study Activities.

Target population and eligibility criteria

Our population includes English-speaking African American patients with ESRD who are age 18 years or older and who have initiated dialysis within one year prior to study enrollment. We exclude participants if they have dementia (assessed in-person) [42] or if they have a self reported history of prior kidney transplant, cancer within 2 years prior to recruitment, stage IV congestive heart failure, end stage liver disease, pulmonary hypertension, severe peripheral vascular disease, or chronic (debilitating) infections. We assess participants’ eligibility via questions administered by a research assistant in-person in dialysis units. After potentially eligible patients agree to participate, we request a release of medical records from each participant to confirm their eligibility for the study and to ascertain whether potential donors have contacted local transplant centers to be evaluated as donors on behalf of participants.

Recruitment of participants

We recruit participants from academically affiliated and community-based dialysis centers in the Baltimore, MD metropolitan region, which we have selected to provide an adequate number of African American participants with new-onset ESRD. We recruit patients on-site from different dialysis centers on different days. We systematically rotate recruitment days at sites so variations in patient scheduling at all sites can be covered to achieve the maximum number of recruitment opportunities. Upon confirmation of their eligibility to participate, we randomly assign patients into intervention groups.

Reimbursement and enrollment of potential kidney donors

Potential kidney donors only become aware of the financial assistance program through direct referral by enrolled study participants. Research study staff do not contact or attempt to contact any family, friends, or acquaintances of enrolled patient participants. Therefore, enrolled participants will be directed to contact study staff in the event they want to refer potential donors to the program. To be eligible to participate, potential donors must speak English and be 18 years or older. Once potential donors contact study staff, study staff arrange for a time to meet with the potential donor(s) in person and mail them the brochure describing the financial assistance program. At that time, study staff explain the financial assistance program to potential donors, including what they will be asked to do as part of the study. Potential donors are notified that participation in the financial assistance program offered by the study may preclude them from receiving financial assistance from any other program (e.g., National Living Donor Assistance Center). If potential donors wish to participate in the financial assistance program, we obtain consent for their participation in the study using approved consent procedures.


Using blind and secure allocation by computer, we randomly assign participants to one of three intervention arms: 1) control group (“Usual Care”, N=70); 2) the informational intervention (“PREPARED”, N=70); and 3) the informational plus the financial assistance interventions (“PREPARED plus Financial Assistance”, N=70). Randomization is blocked by recruitment site to ensure equal allocation within each dialysis facility.

Usual care group

Participants randomly assigned to receive Usual Care proceed with their clinical care in dialysis centers as already routinely implemented by their physicians. At study conclusion, participants will receive informational materials provided in PREPARED (educational video and written handbook) after follow up assessments have been completed.

Intervention groups

Participants randomly assigned to the PREPARED program receive the informational intervention, which consists of an educational video and written handbook intended to be used together to inform patients’ decisions about their kidney disease treatment choices. These materials are provided to participants on a day when they do not receive dialysis in the dialysis center. Participants meet with trained research study staff during which time they are oriented to the book and watch the video. Study staff members also encourage participants to share the materials with their families and health care providers. Participants randomly assigned to the PREPARED plus Financial Assistance program receive the informational intervention at the time of enrollment in a similar fashion with a similar approach to the PREPARED assignment. In addition, participants in this group are invited to participate in the live kidney donor financial assistance program as described above.

Data collection, follow-Up and outcomes

Measures assessed through interventions

All patient participants enrolled in the study are assessed using an in-person questionnaire at the time of recruitment and a structured telephone interview at baseline, 1 month, 3 months, and 6 months. Trained study staff administer all telephone interviews. For the informational and financial intervention arms, participants are contacted via telephone to determine whether they have viewed the materials provided to them (an educational video and written handbook for the informational intervention and the brochure for the financial intervention arm) again at home. Participants are also asked if they have shared or discussed the content of intervention materials with family members.

The primary outcome of interest is patients’ pursuit of LRT over six months of follow up. This outcome is measured as participants’ achievement of at least one of six key steps toward pursuing LRT, including: 1) execution of patient-family discussions about LRT; 2) execution of patient-physician discussions about LRT; 3) initiation of the recipient evaluation for LRT; 4) completion of the recipient evaluation for LRT, 5) identification of a potential live kidney donor, and 6) being listed at a transplant center. Pursuit of LRT will be assessed via questionnaires administered via telephone questionnaire at baseline, 1 month, 3 months and 6 months follow-up time periods. For participants reporting being registered on a transplant waiting list, we will contact transplant centers to determine whether there have been any live donor inquiries on behalf of the participant. We will also assess whether patient participants receive LRT and whether patient participants’ family members inquire about or use the financial assistance program (for those randomized to the PREPARED plus Financial Assistance arm).

Other measures include assessment of participants’ (1) knowledge of LRT; (2) interest in LRT; (3) perceived barriers to LRT; (4) preferred role in decision-making about LRT; (5) concerns about the risks of LRT to themselves and to donors [43-45]; (6) family structure and relationships [46]; (7) interest in other forms of renal replacement therapy (i.e., peritoneal dialysis or home-hemodialysis); (8) satisfaction with hemodialysis therapy; (9) depression and social support [47,48]; (10) financial stress [49]; (11) health literacy [50] and numeracy [51,52]; (12) trust in the medical system [53,54], (13) comorbid conditions [55] and (14) sociodemographic characteristics. For patient participants assigned to the PREPARED and PREPARED plus Financial Assistance groups, we also assess their perceptions of the helpfulness of the video and handbook. In all study groups, we also assess the number of donor inquiries on behalf of study participants at local transplant centers (Table (Table11).

Table 1
Data collected at study baseline and follow up

Statistical considerations

Data analysis

Randomly assigned intervention group (i.e. Usual Care, PREPARED, PREPARED plus Financial Assistance) will be the main independent variable for intent-to-treat analyses. In our primary analyses, we will assess the proportion of participants in each group achieving at least one new LRT pursuit behavior over 6 months. We will use multivariable models (e.g. logistic regression) to assess differences in the odds of achieving LRT pursuit behaviors among study groups while adjusting for study site characteristics and other baseline characteristics found not to be balanced by randomization. Secondary analyses will include exploratory analyses among persons within subgroups defined post-randomization--for example, analyses among persons with greater versus lesser knowledge of LRT at baseline. We will conduct primary analyses under the assumption that data is missing at random, however, we will also perform sensitivity analyses based on other scenarios (i.e. patterns of missing data) to evaluate the robustness of our assumptions.

Sample size and power

We are aware of no other randomized controlled trials evaluating the effectiveness of informational (focused on shared decision-making) or financial interventions on commitment to LRT in incident dialysis patients. In our own work, an educational intervention resulted in patients’ greater pursuit of LRT (30% achieving new LRT behavior in Usual Care arm compared to 50% in education arm over 6 months) [19]. Our own previous work also demonstrated African Americans in the US general public were supportive of live kidney donors receiving reimbursement for expenses related to donation [24]. We anticipate the financial intervention, which addresses a common and tangible barrier to live kidney donation, may improve pursuit of LRT by an additional 10%. Based on these assumptions, we will have over 80% power to detect a trend of increasing pursuit of LRT across groups (e.g., 30% in Usual Care, 50% in PREPARED group, 60% in PREPARED plus Financial Assistance group) at 6 months. We will also have over 80% power to detect a 30% difference between the PREPARED group and the Usual Care group or the PREPARED plus Financial Assistance group and the Usual Care group individually with correction for multiple comparisons.


Inadequate resources to promote shared decision-making about LRT and financial barriers to live kidney donation may contribute to lower rates of LRT among African American compared to Whites [56-58]. We designed PREPARED educational interventions to directly address commonly encountered barriers to African American patients and their family members and health care providers in engaging in informed and shared decision-making regarding pursuit of LRT. We designed the PREPARED plus Financial Assistance intervention to enable patients and their families to overcome the significant barrier of monetary concerns in pursuit of LRT. Rigorous study of these interventions will provide health care providers and policy makers with the evidence necessary to endorse the widespread use of similar interventions in a variety of clinical settings if they are effective.


ESRD: End stage renal disease; LRT: Living related kidney transplants or transplantation, PREPARED, Providing Resources to Enhance African American Patients’ Readiness to Make Decisions about Kidney Disease.

Competing interests

The authors do not declare any competing interests.

Authors’ contributions

PLE contributed to the study design, intervention development, study conduct, and drafting and approval of the manuscript. NRP contributed to the study conception and design, intervention development, study conduct, and drafting and approval of the manuscript. HR contributed to the study conception and design, intervention development, study conduct, and drafting and approval of the manuscript. JA contributed to the intervention development and drafting and approval manuscript. PA contributed to the intervention development and drafting and approval of the manuscript. LLB contributed to the intervention development and drafting and approval of the manuscript. RCG contributed to the intervention development and drafting and approval of the manuscript. DCC contributed to the intervention development and drafting and approval of the manuscript. TSP contributed to the intervention development and drafting and approval of the manuscript. BGG contributed to the intervention development and drafting and approval of the manuscript. ND contributed to the intervention development and drafting and approval of the manuscript. LEB led the study conception and design, intervention development, study conduct, and drafting and approval of the manuscript. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here:


This study is funded by the United States National Institutes of Health, from Grant #R01DK079682 from the National Institute of Diabetes and Digestive and Kidney Diseases. We would like to thank Tope Olufade, PhD and Julio Lamprea Monteleagre, PhD for their valuable contributions to this study.


  • US Renal Data System 2011 Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States . [PubMed]
  • Gaston RS, Ayres I, Dooley LG, Diethelm AG. Racial equity in renal transplantation. the disparate impact of HLA-based allocation. JAMA. 1993;270(11):1352–1356. doi: 10.1001/jama.1993.03510110092038. [PubMed] [Cross Ref]
  • Young CJ, Gaston RS. Renal transplantation in black Americans. N Engl J Med. 2000;343(21):1545–1552. doi: 10.1056/NEJM200011233432107. [PubMed] [Cross Ref]
  • Ayanian JZ, Cleary PD, Weissman JS, Epstein AM. The effect of patients' preferences on racial differences in access to renal transplantation. N Engl J Med. 1999;341(22):1661–1669. doi: 10.1056/NEJM199911253412206. [PubMed] [Cross Ref]
  • Kasiske BL, London W, Ellison MD. Race and socioeconomic factors influencing early placement on the kidney transplant waiting list. J Am Soc Nephrol. 1998;9(11):2142–2147. [PubMed]
  • Soucie JM, Neylan JF, McClellan W. Race and sex differences in the identification of candidates for renal transplantation. Am J Kidney Dis. 1992;19(5):414–419. [PubMed]
  • Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR) 2010 Annual Data Report.
  • Isaacs RB, Lobo PI, Nock SL, Hanson JA, Ojo AO, Pruett TL. Racial disparities in access to simultaneous pancreas-kidney transplantation in the United States. Am J Kidney Dis. 2000;36(3):526–533. doi: 10.1053/ajkd.2000.9793. [PubMed] [Cross Ref]
  • Alexander GC, Sehgal AR. Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA. 1998;280(13):1148–1152. doi: 10.1001/jama.280.13.1148. [PubMed] [Cross Ref]
  • Alexander GC, Sehgal AR. Why hemodialysis patients fail to complete the transplantation process. Am J Kidney Dis. 2001;37(2):321–328. doi: 10.1053/ajkd.2001.21297. [PubMed] [Cross Ref]
  • Boulware LE, Meoni LA, Fink NE. et al. Preferences, knowledge, communication and patient-physician discussion of living kidney transplantation in African American families. Am J Transplant. 2005;5(6):1503–1512. doi: 10.1111/j.1600-6143.2005.00860.x. [PubMed] [Cross Ref]
  • Wolfe RA, Ashby VB, Milford EL. et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–1730. doi: 10.1056/NEJM199912023412303. [PubMed] [Cross Ref]
  • Ichikawa Y, Fujisawa M, Hirose E. et al. Quality of life in kidney transplant patients. Transplant Proc. 2000;32(7):1815–1816. doi: 10.1016/S0041-1345(00)01360-9. [PubMed] [Cross Ref]
  • Jofre R, Lopez-Gomez JM, Moreno F, Sanz-Guajardo D, Valderrabano F. Changes in quality of life after renal transplantation. Am J Kidney Dis. 1998;32(1):93–100. doi: 10.1053/ajkd.1998.v32.pm9669429. [PubMed] [Cross Ref]
  • Manninen DL, Evans RW, Dugan MK. Work disability, functional limitations, and the health status of kidney transplantation recipients posttransplant. Clin Transpl. 1991. pp. 193–203. [PubMed]
  • Whiting JF, Kiberd B, Kalo Z, Keown P, Roels L, Kjerulf M. Cost-effectiveness of organ donation: evaluating investment into donor action and other donor initiatives. Am J Transplant. 2004;4(4):569–573. doi: 10.1111/j.1600-6143.2004.00373.x. [PubMed] [Cross Ref]
  • Ojo A, Port FK. Influence of race and gender on related donor renal transplantation rates. Am J Kidney Dis. 1993;22(6):835–841. [PubMed]
  • Purnell TS, Hall YN, Boulware LE. Understanding and overcoming barriers to living kidney donation among racial and ethnic minorities in the United States. Adv Chronic Kidney Dis. 2012;19(4):244–251. doi: 10.1053/j.ackd.2012.01.008. [PMC free article] [PubMed] [Cross Ref]
  • Boulware LE, Ephraim P, Hill-Briggs F. et al. Effectiveness of educational and behavioral interventions to improve pursuit of pre-emptive living-related kidney transplantation: The Talking About Living Kidney Donation (TALK) Study. Am J Transplant. 2011;2:28–211. doi: 10.1111/j.1600-6143.2011.03533.x. [Cross Ref]
  • Finkelstein FO, Story K, Firanek C. et al. Perceived knowledge among patients cared for by nephrologists about chronic kidney disease and end-stage renal disease therapies. Kidney Int. 2008;74(9):1178–1184. doi: 10.1038/ki.2008.376. [PubMed] [Cross Ref]
  • Shilling LM, Norman ML, Chavin KD. et al. Healthcare professionals' perceptions of the barriers to living donor kidney transplantation among African Americans. J Natl Med Assoc. 2006;98(6):834–840. [PMC free article] [PubMed]
  • Clarke KS, Klarenbach S, Vlaicu S, Yang RC, Garg AX. The direct and indirect economic costs incurred by living kidney donors-a systematic review. Nephrol Dial Transplant. 2006;21(7):1952–1960. doi: 10.1093/ndt/gfl069. [PubMed] [Cross Ref]
  • Boulware LE, Ratner LE, Sosa JA. et al. The general public's concerns about clinical risk in live kidney donation. Am J Transplant. 2002;2(2):186–193. doi: 10.1034/j.1600-6143.2002.020211.x. [PubMed] [Cross Ref]
  • Boulware LE, Troll MU, Wang NY, Powe NR. Public attitudes toward incentives for organ donation: a national study of different racial/ethnic and income groups. Am J Transplant. 2006;6(11):2774–2785. doi: 10.1111/j.1600-6143.2006.01532.x. [PubMed] [Cross Ref]
  • The National Live Donor Assistance Program.
  • Sheu J, Ephraim PE, Powe NR. et al. African American and non-African American patients’ and families’ experiences with decision making about renal replacement therapies. Qual Health Res. 2012;22(7):997–1006. doi: 10.1177/1049732312443427. [PubMed] [Cross Ref]
  • Auguste P, Greer RC, Ephraim P. et al. Quality of evidence informing patients' choice of renal replacement modalty (RRM) [abstract] Clin J Am Soc Nephrol. 2010;21:539A. (Proceedings of the American Society of Nephrology Renal Week 2010)
  • Olufade T, Auguste P, Crews D. et al. Comparison of sexual dysfunction between renal replacement therapies: a systematic review [abstract] J Am Soc Neph. 2011;22:204A. (Proceedings of the American Society of Nephrology Kidney Week)
  • Crews D, Auguste P, Purnell TS. et al. Comparison of cognitive function across esrd treatment modalities: a systematic review [abstract] J Am Soc Neph. 2011;22:256A. (Proceedings of the American Society of Nephrology Kidney Week)
  • Purnell T, Auguste P, Crews D. et al. Comparison of life participation outcomes between renal replacement therapy modalities: a systematic review [abstract] J Am Soc Neph. 2011;22:734A. Proceedings of the American Society of Nephrology Kidney Week)
  • Israni AK, Halpern SD, Zink S, Sidhwani SA, Caplan A. Incentive models to increase living kidney donation: encouraging without coercing. Am J Transplant. 2005;5(1):15–20. doi: 10.1111/j.1600-6143.2004.00656.x. [PubMed] [Cross Ref]
  • Goyal M, Mehta RL, Schneiderman LJ, Sehgal AR. Economic and health consequences of selling a kidney in India. JAMA. 2002;288(13):1589–1593. doi: 10.1001/jama.288.13.1589. [PubMed] [Cross Ref]
  • Matas AJ, Schnitzler M, Daar AS. Payment for living kidney donors (vendors) is not an abstract ethical discussion occurring in a vacuum. Am J Transplant. 2004;4(8):1380–1381. doi: 10.1111/j.1600-6143.2004.00487.x. [PubMed] [Cross Ref]
  • Organ Donation. Opportunities for Action . Washington, DC: The National Academies Press; 2006.
  • Davis CL, Delmonico FL. Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol. 2005;16(7):2098–2110. doi: 10.1681/ASN.2004100824. [PubMed] [Cross Ref]
  • Jacobs C, Thomas C. Financial considerations in living organ donation. Prog Transplant. 2003;13(2):130–136. [PubMed]
  • Gaston RS, Danovitch GM, Epstein RA, Kahn JP, Matas AJ, Schnitzler MA. Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant. 2006;6(11):2548–2555. doi: 10.1111/j.1600-6143.2006.01492.x. [PubMed] [Cross Ref]
  • Wolters HH, Heidenreich S, Senninger N. Living donor kidney transplantation: chance for the recipient–financial risk for the donor? Transplant Proc. 2003;35(6):2091–2092. doi: 10.1016/S0041-1345(03)00675-4. [PubMed] [Cross Ref]
  • Steinbrook R. Public solicitation of organ donors. N Engl J Med. 2005;353(5):441–444. doi: 10.1056/NEJMp058151. [PubMed] [Cross Ref]
  • Monaco AP. Rewards for organ donation: the time has come. Kidney Int. 2006;69(6):955–957. doi: 10.1038/ [PubMed] [Cross Ref]
  • Elwyn G, O'Connor A, Stacey D. et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333(7565):417. doi: 10.1136/bmj.38926.629329.AE. [PMC free article] [PubMed] [Cross Ref]
  • Borson S, Scanlan J, Chen P, Ganguli M. The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc. 2003;51(10):1451–1454. doi: 10.1046/j.1532-5415.2003.51465.x. [PubMed] [Cross Ref]
  • Stage of Decision Making.
  • Decision Conflict Scale.
  • Decision Self-Efficacy Scale.
  • Good MJD, Smilkstein G, Good BJ, Shaffer T, Arons T. The family APGAR index: a study of construct validity. J Fam Pract. 1979;8:577–582.
  • Patient Reported Outcomes Measurement Information System (PROMIS) Social Functioning Health Bank.
  • Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of prime-md: the phq primary care study. primary care evaluation of mental disorders. patient health questionnaire. JAMA. 1999;282(18):1737–1744. doi: 10.1001/jama.282.18.1737. [PubMed] [Cross Ref]
  • Prawitz AD, Garman ET, Sorhaindo B, Kim J, O'Neill B, Drentea P. InCharge financial distress/financial well-being scale: development, norming, and score interpretation. Financ Couns Plan. 2006;17(1):34–50.
  • Davis TC, Long SW, Jackson RH, Mayeaux EJ, George RB, Crouch MA. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med. 1993;25(6):391–395. [PubMed]
  • Fagerlin A, Zikmund-Fisher BJ, Ubel PA, Jankovic A, Derry HA, Smith DM. Measuring numeracy without a math test: Development of the Subjective Numeracy Scale (SNS) Med Decis Making. 2007;27:672–680. doi: 10.1177/0272989X07304449. [PubMed] [Cross Ref]
  • Schapira MM, Davids SL, McAuliffe TL, Nattinger AB. Agreement between scales in the measurement of breast cancer risk perceptions. Risk Anal. 2004;24(3):665–673. doi: 10.1111/j.0272-4332.2004.00466.x. [PubMed] [Cross Ref]
  • LaVeist TA, Isaac LA, Williams KP. Mistrust of health care organizations is associated with underutilization of health services. Health Serv Res. 2009;44(6):2093–2105. doi: 10.1111/j.1475-6773.2009.01017.x. [PMC free article] [PubMed] [Cross Ref]
  • Corbie-Smith G, Thomas SB, St Georg DM. Distrust, race, and research. Arch Intern Med. 2002;162(21):2458–2463. doi: 10.1001/archinte.162.21.2458. [PubMed] [Cross Ref]
  • Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the charlson comorbidity index for use in patients with ESRD. Am J Kidney Dis. 2003;42:125–132. doi: 10.1016/S0272-6386(03)00415-3. [PubMed] [Cross Ref]
  • U.S. Department of Health and Human Services News. Organ donations increase in 1998 following national initiative and new regulations .
  • United Network for Organ Sharing. OPTN / SRTR 2010 Annual Data Report . Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011.
  • Rovner DR, Wills CE, Bonham V. et al. Decision aids for benign prostatic hyperplasia: applicability across race and education. Med Decis Making. 2004;24(4):359–366. doi: 10.1177/0272989X04267010. [PubMed] [Cross Ref]

Articles from BMC Nephrology are provided here courtesy of BioMed Central